While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsche Bank lowered the boom on Thursday.
Similar stories
1 outlet
Novo Nordisk Stock Is Downgraded to Sell, and GLP-1s Aren’t the Reason
barrons.com
27.08.2026
Related stories
Think Nvidia Is Overpriced? The Irony Keeps Me Buying Again and Again
Prediction: This Is What a $5,000 Investment in Broadcom Will Be Worth by 2028
Real REMAX Group (REAX) Stock Weakness Reflects Fears of AI-Driven Market Changes
The 10-Year Treasury Broke 5% and Long Bond Holders Are Not Getting Rescued
Bloom Energy Corp. (BE) Short Position Weighs on Performance Amid Small-Cap AI Rally
Geron Eyes High End of 2026 RYTELO Revenue Guidance as Community Adoption Expands